Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India
- PMID: 17559381
- DOI: 10.1111/j.1440-1746.2007.04908.x
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India
Abstract
Aim: To assess the role of hepatitis B virus (HBV), hepatitis C virus (HCV) and alcohol intake as risk factors for hepatocellular carcinoma (HCC) in the presence or absence of cirrhosis in Indian population.
Methods: A total of 213 patients with HCC and 254 control subjects not affected with hepatic diseases or neoplasm were recruited. Odds ratios (ORs) were estimated for each risk factor and synergism among various risk factors was also studied.
Results: The ORs and 95% confidence intervals (CI) of HCC were 48.02 (25.06-91.98) for any HBV marker, 38.98 (19.55-77.71) for HBsAg positivity, 12.34 (2.84-53.61) for HBsAg negative and antibody positive (either of anti-HBe or total anti-HBc), 5.45 (2.02-14.71) for anti-HCV positive and HCV RNA positive, and 2.83 (1.51-5.28) for heavy alcohol use. No significant risk increase was evident for subjects who were anti-HCV positive and HCV RNA negative. Synergism between alcohol and HCV infection in causing HCC was found, but not between alcohol and HBV. Overall, conclusive evidence of the presence or absence of cirrhosis was reached in 189 (88.73%) HCC patients; cirrhosis was present in 137 (72.48%) of them. ORs with 95% CI of HCC in the presence and absence of cirrhosis, respectively, for HBV were as follows: (i) 48.90 (24.61-97.19) and 35.03 (15.59-78.66) for any HBV marker; (ii) 39.88 (19.41-81.97) and 24.40 (10.60-56.18) for HBsAg positivity; and (iii) 12.10 (2.67-54.88) and 19.60 (3.94-97.39) for HBsAg negativity and antibody positivity. Significantly increased risk was found among cirrhotic patients for anti-HCV positivity and HCV RNA positivity [OR = 7.53 (2.73-20.78)] and for heavy alcohol use [OR = 3.32 (1.70-6.47)]; however, in the absence of cirrhosis, no significant risk increase was evident for subjects who were anti-HCV positive and HCV RNA positive [OR = 0.97 (0.11-8.54)], or who had history of heavy alcohol use [OR = 1.58 (0.55-4.53)].
Conclusions: Infection with HBV and HCV are the major risk factors for the development of HCC in Indian patients. Presence of HBV antibodies even in the absence of HBsAg conferred increased risk for HCC in the presence or absence of cirrhosis. Anti-HCV positivity in the absence of HCV RNA conferred no increased risk. HCV RNA positivity and heavy alcohol use significantly increased the risk of HCC among cirrhotic patients, but not non-cirrhotic patients.
Similar articles
-
Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.Am J Gastroenterol. 2002 Nov;97(11):2886-95. doi: 10.1111/j.1572-0241.2002.07057.x. Am J Gastroenterol. 2002. PMID: 12425564
-
Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):213-6. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10698484
-
[The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].Korean J Hepatol. 2008 Mar;14(1):67-76. doi: 10.3350/kjhep.2008.14.1.67. Korean J Hepatol. 2008. PMID: 18367859 Korean.
-
Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.
-
Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.J Hepatol. 1996;24(2 Suppl):61-6. J Hepatol. 1996. PMID: 8836891 Review.
Cited by
-
Development and Validation of a Novel Prognosis Model Based on a Panel of Three Immunogenic Cell Death-Related Genes for Non-Cirrhotic Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2023 Sep 25;10:1609-1628. doi: 10.2147/JHC.S424545. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37781718 Free PMC article.
-
Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea.Ann Occup Environ Med. 2018 Jan 31;30:6. doi: 10.1186/s40557-018-0217-0. eCollection 2018. Ann Occup Environ Med. 2018. PMID: 29423229 Free PMC article. Review.
-
Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy.J Pers Med. 2023 Feb 24;13(3):397. doi: 10.3390/jpm13030397. J Pers Med. 2023. PMID: 36983579 Free PMC article.
-
Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.Dig Dis Sci. 2022 Jun;67(6):2677-2687. doi: 10.1007/s10620-021-07048-5. Epub 2021 May 23. Dig Dis Sci. 2022. PMID: 34027591 Free PMC article.
-
Hepatocellular Carcinoma (HCC) in North-Western India: A Retrospective Study Focusing on Epidemiology, Risk Factors, and Survival.J Gastrointest Cancer. 2022 Dec;53(4):921-929. doi: 10.1007/s12029-021-00712-z. Epub 2021 Sep 22. J Gastrointest Cancer. 2022. PMID: 34550547
MeSH terms
LinkOut - more resources
Full Text Sources
Medical